Treatment of Symptomatic Polyneuropathy With Actovegin in Type 2 Diabetic Patients

OBJECTIVE: To evaluate the efficacy and safety of actovegin in patients with diabetic polyneuropathy. RESEARCH DESIGN AND METHODS: In this multicenter, randomized, double-blind trial, 567 patients with type 2 diabetes received 20 intravenous infusions of actovegin (2,000 mg/day) (n = 281) or placebo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziegler, Dan, Movsesyan, Lusine, Mankovsky, Boris, Gurieva, Irina, Abylaiuly, Zhangentkhan, Strokov, Igor
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713653/
https://www.ncbi.nlm.nih.gov/pubmed/19470838
http://dx.doi.org/10.2337/dc09-0545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713653/
https://www.ncbi.nlm.nih.gov/pubmed/19470838
http://dx.doi.org/10.2337/dc09-0545

Ejemplares similares